Strives Earnings Show Wider Losses, Yet Shares Climb 25% MTD

Strive (ASST) reported its fiscal 2025 Q4 earnings on March 19, 2026, revealing a revenue increase but a significant widening of its net loss. The company’s shares have shown strong short-term price momentum, climbing 25.43% month-to-date, though post-earnings trading strategies have historically underperformed. Management emphasized progress in digital credit and Bitcoin accumulation, despite ongoing financial challenges.

Revenue

The total revenue of Strive increased by 21.4% to $1.26 million in 2025 Q4, up from $1.03 million in 2024 Q4.

Earnings/Net Income

Strive narrowed its per-share loss to $0.23 in 2025 Q4 from $0.42 in 2024 Q4, reflecting a 45.2% improvement. However, the company’s net loss surged to $-201.31 million, a 4788.6% increase from $-4.12 million in the prior year. The widening deficit underscores structural challenges, as Strive has posted losses in each of the past four Q4s. The EPS improvement is a positive signal, but the dollar-scale loss highlights unsustainable financial dynamics.

Price Action

Strive’s stock price has climbed 5.77% during the latest trading day, 16.19% over the past week, and 25.43% month-to-date, reflecting investor optimism despite earnings underperformance.

Post-Earnings Price Action Review

The strategy of buying Strive (ASST) shares after a revenue drop quarter-over-quarter on the financial report release date and holding for 30 days resulted in a significant underperformance. Over the past three years, the strategy yielded a return of -89.15%, with a benchmark return of 62.59% and an excess return of -151.74%. The strategy’s CAGR was -51.16%, indicating a substantial loss in value. The strategy also had a high maximum drawdown of 97.64% and a Sharpe ratio of -0.19, suggesting considerable risk and volatility.

CEO Commentary

Matthew Cole, Chairman & CEO of Strive, Inc., emphasized the company’s successful foundation as a structured finance entity focused on digital credit, highlighting a multi-trillion-dollar growth opportunity in the sector. He noted the SATA product’s potential to deliver double-digit yields with minimal volatility, underscoring a strategic focus on maintaining a stable trading range and strong balance sheet to generate long-term returns for common equity stockholders relative to Bitcoin’s performance. The commentary reflected optimism about scaling digital credit solutions while balancing Bitcoin accumulation with operational monetization, particularly through Clinivanta’s healthcare initiatives.

Guidance

Strive expects to capitalize on the expanding digital credit market, leveraging SATA as a scalable solution for investors seeking yields. The company aims to sustain a stable trading range for its shares and maintain a robust balance sheet to support long-term returns, aligning with its Bitcoin hurdle rate. Forward-looking statements include confidence in the multi-trillion-dollar digital credit opportunity and the execution of its structured finance strategy, though no specific financial metrics or timelines were quantified.

Additional News

Strive has amassed 13,628 Bitcoin, placing it among the top 10 corporate holders globally, despite a $393.6 million net loss in its first six months as a public company. The accumulation included 5,048 Bitcoin from the Semler Scientific acquisition, which added a healthcare-focused subsidiary, Clinivanta. Yorkville Advisors Global LP also purchased a new stake in Strive during Q3, signaling institutional interest. Michelle Fox, former Teleflex CMO, was appointed CEO of Clinivanta in February 2026, reflecting a strategic shift to develop the healthcare division alongside Bitcoin operations.